ATACAND PLUS Trademark

Trademark Overview

On Tuesday, February 25, 2003, a trademark application was filed for ATACAND PLUS with the United States Patent and Trademark Office. The USPTO has given the ATACAND PLUS trademark a serial number of 78218771. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, June 13, 2007. This trademark is owned by AstraZeneca AB. The ATACAND PLUS trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.

General Information

Serial Number78218771
Word MarkATACAND PLUS
Filing DateTuesday, February 25, 2003
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, June 13, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 19, 2006

Trademark Statements

Disclaimer with Predetermined Text"PLUS"
Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 18, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSodertalje S-151 85
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSodertalje S-151 85
SE

Trademark Events

Event DateEvent Description
Monday, December 10, 2007ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Thursday, December 6, 2007ABANDONMENT - NO USE STATEMENT FILED
Monday, July 23, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 23, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 12, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 19, 2006PUBLISHED FOR OPPOSITION
Wednesday, August 30, 2006NOTICE OF PUBLICATION
Wednesday, July 26, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 24, 2006ASSIGNED TO LIE
Friday, June 2, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 1, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 1, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 31, 2006ASSIGNED TO LIE
Wednesday, March 29, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2006EXAMINER'S AMENDMENT ENTERED
Wednesday, March 29, 2006EXAMINERS AMENDMENT E-MAILED
Wednesday, March 29, 2006EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 18, 2005CORRESPONDENCE E-MAILED
Tuesday, October 18, 2005NON-FINAL ACTION WRITTEN
Tuesday, October 4, 2005PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, September 20, 2005WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, July 1, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 24, 2005ASSIGNED TO LIE
Monday, June 20, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 17, 2005AMENDMENT FROM APPLICANT ENTERED
Thursday, June 9, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 9, 2005PAPER RECEIVED
Friday, April 22, 2005FINAL REFUSAL E-MAILED
Friday, April 22, 2005FINAL REFUSAL WRITTEN
Friday, March 26, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 17, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 19, 2004PAPER RECEIVED
Thursday, August 14, 2003NON-FINAL ACTION E-MAILED
Thursday, August 14, 2003ASSIGNED TO EXAMINER

Related Keywords

plus atacand diseases cardiovascular treatment preparations pharmaceutical